Seeking a COVID-19 vaccination before Christmas? Saginaw’s Dow Event Center will host a Tuesday clinic
SAGINAW, MI — Saginaw County Health Department officials this week will host the last COVID-19 vaccination clinic of 2021, just days before many families gather for Christmas. A walk-in clinic is scheduled from 9 a.m. to 3:30 p.m. Tuesday, Dec. 21, at The Dow Event Center in downtown Saginaw. Booster shots for Moderna or Pfizer vaccines are recommended at least six months after the previous shot. Booster shots for the Johnson and Johnson booster are recommended at least two months after the previous shot. This week, exactly 50% of Saginaw County residents were reported fully vaccinated, according to the Centers for Disease Control and Prevention.
mlive.comFauci: Likely those who received J&J vaccine will also be recommended for booster
The White House announced Friday that Dr. Anthony Fauci, medical advisor to President Joe Biden, said he expects Americans who received the one-dose J&J vaccine against COVID-19 also will be recommended for a booster shot.
US doses arrive as Nepal struggles to vaccinate population
A shipment of 1.5 million doses of Johnson and Johnson vaccine donated by the United States arrived Monday in Nepal, which is struggling to inoculate its population against the coronavirus. “Today's delivery of the single-dose vaccine means that this single donation is enough to protect over 1.5 million people in Nepal," U.S. Ambassador Randy Berry said at Kathmandu airport. The U.S. is also donating vaccines to several other Asian countries, including Indonesia, Malaysia and Thailand.
news.yahoo.comJohnson & Johnson's one-dose shot could be vital to vaccinating the rest of the country. But has it missed a critical moment?
"There have been interruptions, there have been concerns, and there's even been the pause," one state official said. "And because of that, it has at times really not lived up to that promise that we all would have liked here for the J&J vaccine."
cbsnews.comMiami Black leaders launch vaccine campaign to counter hesitancy after J&J pause
The impact of the two-week pause by federal health officials of the one-shot Johnson & Johnson vaccine is still being felt in the Liberty City area, where Congresswoman Frederica Wilson spoke Tuesday at the site of a makeshift cemetery memorializing the lives of Black Miami-Dade residents lost to COVID.
news.yahoo.comCDC panel needs more time to weigh risks of Johnson & Johnson's coronavirus vaccine
The CDC says it needs more time to weigh the risks of the Johnson & Johnson vaccine. An advisory panel met Wednesday but said it did not have enough information to make a decision, leaving a temporary pause on the vaccine in place. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joins CBSN's Lana Zak with more on the fate of the Johnson and Johnson vaccine.
cbsnews.comCDC holds emergency meeting on Johnson & Johnson vaccine
The FDA and CDC are trying to determine whether the Johnson and Johnson vaccine is linked to a handful of blood clotting cases, one of them fatal. Tanya Rivero spoke with John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, about the new concerns.
cbsnews.comCDC prepares to hold emergency meeting on Johnson and Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joins CBSN AM with the latest.
cbsnews.comCDC prepares to hold emergency meeting on Johnson and Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joined "CBSN AM" with the latest.
cbsnews.comPause of J&J COVID-19 vaccine shows ‘safety checks in place,’ Spectrum Health doctor says
The Associated Press reported that the six reported blood clots all occurred in women between the ages of 18 and 48. The Grand Rapids-based health system has administered 4,391 doses of the J&J vaccine and has an additional 655 doses on hand. That includes 301,481 first- and second doses of the Pfizer and Moderna vaccine, as well as the 4,391 doses of the J&J vaccine. He said Spectrum has not canceled any vaccine clinics in response to the J&J vaccine distribution pause. That’s because Spectrum was not exclusively distributing the J&J vaccine at any of its clinics.
mlive.comDetroit expands COVID vaccine eligibility to all residents 16 and older
Robert Huguley, 74, receives Moderna's COVID-19 vaccine, Jan. 27, 2021, at the TCF Center in Detroit. (AP Photo/Carlos Osorio)DETROIT – All Detroiters 16 and older are now eligible for a COVID-19 vaccine, the city announced Monday. Any Detroit resident age 16 or older can now call to schedule an appointment to be vaccinated at the TCF Center. Johnson & Johnson vaccine site opened at Northwest Activities Center 9-1 this Saturday. Chief Public Health Officer Denise Fair also announced that the Detroit Health Department has been informed it will receive its first allocation of Johnson and Johnson vaccine this week.
No, the Johnson & Johnson coronavirus vaccine is not inferior, Michigan doctors say
Dr. Liam Sullivan may have more reason than most to be enthusiastic about approval of the new Johnson & Johnson vaccine. “I am completely confident in the clinical trial that Johnson & Johnson ran and the protection of this vaccine,” Sullivan said. But the J&J vaccine has come under scrutiny, especially after Detroit Mayor Mike Duggan said last week that he rejected an offer of J&J vaccines for the city’s vaccinations. “The J&J vaccine is not inferior,” said Dr. Beth Wendt, , director of clinical operational effectiveness at McLaren Macomb Hospital. Meanwhile, the J&J vaccine has some real advantages over the Pfizer and Moderna vaccines, doctors say.
mlive.comBiden boosts US vaccine stockpile as world waits
White House aides said Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. AdRussia has sent millions of doses of its Sputnik V vaccine to countries around the world, even as it vaccinates its own population. Israel, which has vaccinated more than half of its population with Pfizer vaccines produced in Europe, has also attempted to use vaccine diplomacy to reward allies. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Johnson & Johnson's one-shot Covid vaccine cleared for use in the EU
Athens City-County Health Department Director of Nursing, Crystal Jones, 52, loads syringes with the vaccine on the first day of the Johnson and Johnson vaccine. LONDON — The European Union on Thursday authorized the use of the one-dose coronavirus vaccine created by Johnson & Johnson, adding another weapon in the armory being used to fight Covid-19. Europe's drug regulator gave its recommendation earlier on Thursday with the EU Commission giving formal approval later in the day. Two-dose vaccines developed by Pfizer-BioNTech, Moderna and AstraZeneca and the University of Oxford have also been approved. While it's easier to distribute, the vaccine has not been found to be as effective as Pfizer and Moderna's shots at preventing Covid infection.
cnbc.comBiden doubles order of one-shot coronavirus vaccine
Biden doubles order of one-shot coronavirus vaccine The Biden administration is buying 200 million doses of the one-shot vaccine from Johnson & Johnson, meaning the U.S. could have a vaccine surplus by the end of the year. Nancy Cordes has the latest.
cbsnews.comBiden boosts US vaccine stockpile as world waits
White House aides said Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. AdRussia has sent millions of doses of its Sputnik V vaccine to countries around the world, even as it vaccinates its own population. Israel, which has vaccinated more than half of its population with Pfizer vaccines produced in Europe, has also attempted to use vaccine diplomacy to reward allies. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Johnson & Johnson vaccine research method creates conflict for Catholics
The pandemic has ended so many lives and vaccines are in high demand, but the J&J vaccine is born out of research that the church has long spoken out against. AdMichigan COVID-19 vaccinations: How to find appointments, info on phasesWhile the Archdiocese of Detroit recognizes the need for more vaccines, the J&J vaccine emerged from research dating back to the 1970s that proves controversial for Catholics. “If no other vaccines are available, certainly take the J&J vaccine,” Smetanka said. The vaccines developed by Johnson & Johnson and AstraZeneca are more morally problematic, however. If one does not have a choice of vaccine and a delay in immunization may bring about serious consequences for one’s health and the health of others, it would be permissible to accept the Johnson & Johnson or AstraZeneca vaccine.
Detroit mayor rejects initial J&J vaccine shipment, saying Pfizer and Moderna are 'the best'
Detroit Mayor Mike Duggan rejected an initial allotment of the single-shot Johnson & Johnson Covid-19 vaccine this week, according to the Michigan state health department. While some have raised concern over the J&J vaccine's lower efficacy rate, the J&J vaccine has proven to prevent 100% of virus-related hospitalizations and deaths, according to its clinical trial data. He is very eager for the Johnson & Johnson vaccine. "As vaccine eligibility expands, Detroit will open a second site offering Johnson & Johnson vaccines. I have full confidence that the Johnson & Johnson vaccine is both safe and effective."
cnbc.comExpert weighs in on double masks and the Johnson & Johnson shot
Expert weighs in on double masks and the Johnson & Johnson shot Some people are skeptical of getting the new Johnson & Johnson COVID-19 shot because of its efficacy rate or because of moral objections. Dr. Bob Lahita joined CBSN with what the science says about the vaccines, whether to wear two masks and more.
cbsnews.comCanada clears Johnson & Johnson vaccine, first to approve 4
FILE - This Dec. 2, 2020, file photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two (Johnson & Johnson via AP)TORONTO, ONT – Canada is getting a fourth vaccine to prevent COVID-19 as the country's health regulator has cleared a Johnson & Johnson shot that works with just one dose instead of two, officials said Friday. Prime Minister Justin Trudeau said Canada has an agreement with Johnson & Johnson for 10 million doses before September. Trudeau said officials have been assured by the European Union that Pfizer and Moderna vaccine deliveries to Canada won't be disrupted. He said Canada won't get AstraZeneca vaccines doses from Europe for months.
Biden ramps up COVID-19 vaccine production as states start lifting restrictions
Biden ramps up COVID-19 vaccine production as states start lifting restrictions To help ramp up vaccination efforts, the pharmaceutical company Merck has agreed to help mass-produce Johnson and Johnson's single-dose coronavirus vaccine. President Biden now says there will be enough doses for every adult in the country by the end of May. CBS News correspondent Janet Shamlian reports from Houston, and Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano to discuss the latest.
cbsnews.comMerck to help manufacture Johnson & Johnson COVID-19 vaccine
DETROIT – President Joe Biden announced that pharmaceutical giant Merck & Co. will help manufacture Johnson & Johnson’s COVID-19 vaccine. The arrangement comes after officials found out that Johnson & Johnson had fallen behind on production. Johnson & Johnson has pledged 16 million additional doses by the end of the month. READ: Michigan loosens COVID restrictions on restaurants -- here are all the detailsMichigan is also playing a role in the Johnson & Johnson vaccine. READ: Grand Rapids-based Grand River Aseptic to help manufacture J&J vaccineAdQuestions about coronavirus?
Expert weighs in on Johnson & Johnson's one-dose COVID-19 vaccine
Expert weighs in on Johnson & Johnson's one-dose COVID-19 vaccine The third coronavirus vaccine to receive emergency-use authorization from the Food and Drug Administration is being rolled out across the U.S. Medical trials found the Johnson and Johnson vaccine is 85% effective against severe illness. John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, joined CBSN to discuss.
cbsnews.com6 things you need to know about new Johnson & Johnson COVID-19 vaccine
Michigan will be getting 82,700 doses this week of the new COVID-19 vaccine produced by Johnson and Johnson, according to the Michigan Department of Health and Human Services. Michigan will be getting almost a half-million COVID-19 vaccine doses this weekThe J&J vaccine was granted emergency use authorization Saturday, Feb. 27, by the federal Food and Drug Administration. Because the J&J vaccine is only one dose, that process is shortened. The Pfizer vaccine is especially fragile: It must be stored and shipped between -112 to -76 degrees, requiring dry ice and special freezers. The Johnson & Johnson vaccine uses viral vector technology.
mlive.comJohnson and Johnson Begin Vaccine Distribution After Receiving FDA Emergency Authorization
(CBS DETROIT)– After receiving emergency authorization from the FDA over the weekend Johnson and Johnson started rolling out their one dose vaccines on Monday. “It did seem to completely prevent people from really getting so sick that they died from the virus. The Pfizer vaccine is produced in Portage. Officials with Henry Ford Health which participated in a J and J trail says studies show it may protect against a new variant. Health officials expect Michigan will intially receive a little over 80,000 doses of the Johnson and Johnson vaccine.
detroit.cbslocal.comJohnson and Johnson Begin Vaccine Distribution After Receiving FDA Emergency Approval
(CBS DETROIT)– After receiving emergency approval from the FDA over the weekend Johnson and Johnson started rolling out their one dose vaccines on Monday. “It did seem to completely prevent people from really getting so sick that they died from the virus. The Pfizer vaccine is produced in Portage. Officials with Henry Ford Health which participated in a J and J trail says studies show it may protect against a new variant. Health officials expect Michigan will intially receive a little over 80,000 doses of the Johnson and Johnson vaccine.
detroit.cbslocal.comEye Opener: FDA greenlights Johnson & Johnson COVID-19 vaccine
Eye Opener: FDA greenlights Johnson & Johnson COVID-19 vaccine The FDA has granted emergency use authorization for Johnson and Johnson's single-shot COVID-19 vaccine. Also, former President Trump signaled a possible 2024 White House run. All that and all that matters in today's Eye Opener. Your world in 90 seconds.
cbsnews.comFDA and CDC advisory panel approve third coronavirus vaccine for Americans
FDA and CDC advisory panel approve third coronavirus vaccine for Americans Which vaccine is the most effective against the coronavirus? The Moderna and Pfizer vaccines require two shots to be fully vaccinated. However, the new Johnson and Johnson vaccine uses a one-shot method and is easier to store. CBS News researcher Max Bayer joins CBSN's Land Zak to discuss the difference between the vaccines, their efficacy against variants, and if pregnant women should be vaccinated.
cbsnews.comDeveloping world lagging behind in effort to inoculate populations
Developing world lagging behind in effort to inoculate populations South Africa has launched its mass COVID-19 vaccination campaign with the shot developed by Johnson & Johnson, which has not been approved for use anywhere in the world. The move underscores the desperation in the developing world to fight the coronavirus. Debora Patta reports.
cbsnews.comDoctor discusses testing for COVID-19 variants and Johnson & Johnson's vaccine
Doctor discusses testing for COVID-19 variants and Johnson & Johnson's vaccine A third coronavirus vaccine could be available in the U.S. by the end of the month. Johnson and Johnson has asked the Food and Drug Administration to authorize its vaccine for emergency use. "CBS This Morning" lead national correspondent David Begnaud reports several of the new variants of the virus are spreading, and CBSN's Tanya Rivero spoke with infectious disease specialist Dr. Uzma Syed, director of the Antimicrobial Stewardship Center of Excellence at Good Samaritan Hospital Medical Center in New York.
cbsnews.comEye Opener: Johnson & Johnson requests FDA approval for single-shot vaccine
Eye Opener: Johnson & Johnson requests FDA approval for single-shot vaccine Pharmaceutical company Johnson & Johnson is asking the FDA to grant emergency use authorization for its single-shot coronavirus vaccine. Also, former President Trump has rejected a request by House Democrats to testify under oath at his second impeachment trial. All that and all that matters in today's Eye Opener. Your world in 90 seconds.
cbsnews.comJohnson and Johnson finds COVID-19 vaccine 85% effective against severe cases
Johnson and Johnson finds COVID-19 vaccine 85% effective against severe cases Johnson and Johnson's single shot COVID-19 vaccine is bringing new hope in the race to vaccinate Americans. Trials showed the vaccine largely prevented moderate and severe cases. Mola Lenghi has the latest.
cbsnews.comJohnson & Johnson and Novavax COVID vaccines offer promising results
Johnson & Johnson and Novavax COVID vaccines offer promising results Pharmaceutical company Johnson and Johnson says its single-shot coronavirus vaccine has proven effective at preventing severe illness in clinical trials. This comes as a new variant of the virus, originally seen in South Africa, has surfaced in the U.S. CBS News' Mola Lenghi reports, and Dr. Annette Reboli of Cooper Medical School of Rowan University joins CBSN's Tanya Rivero to discuss the latest developments.
cbsnews.comVaccine makers work to take on coronavirus variants
Vaccine makers work to take on coronavirus variants Johnson and Johnson has reported promising results from its single-dose coronavirus vaccine and plans to apply for emergency use authorization in early February. Meanwhile, the virus variant first identified in South Africa has now been found in the United States. CBS News' Mola Lenghi reports, and Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the highly contagious new strain and the work drugmakers are doing to fight variants that continue to appear.
cbsnews.com2 experimental COVID-19 vaccines reach critical milestone -- What does this mean?
DETROIT – There has been some progress involving two of the experimental vaccines for COVID-19. The vaccines have reached a critical milestone, one by the numbers, and one in beginning testing in a new age group. Moderna, the first company to start a U.S. clinical trial of a COVID-19 vaccine, has reached its target of enrolling 30,000 participants. READ: Poll: Michigan voters wary of getting COVID-19 vaccineMeanwhile, Pfizer is hitting its own milestone. The two other late-stage trials are by Johnson & Johnson and Astrazeneca.
Earnings season is a critical test for a stock market on the road back to a record
Its stock rose 1.9% in Tuesday's premarket to $104.40 a share, after its earnings beat. Since the pandemic, companies have provided various amounts of visibility into their businesses, but many companies have still not provided guidance. Deutsche Bank said second-quarter earnings beat at an unprecedented rate of 85%. On just an earnings beat, the stock traded higher just half the time — and on average gained 4.22% to the next earnings report," Birinyi said. Some of the companies that have not yet provided guidance include Illinois Toolworks, IDEXX, Union Pacific, Mastercard, and Intuitive Surgical.
cnbc.comCOVID-19 vaccine manufacturers join together to pledge no corners will be cut
After concern arose that the development of a coronavirus (COVID-19) vaccine might be rushed for reasons other than public health, vaccine manufacturers have joined together to assure the public that no corners will be cut. READ: Whitmer signs bill to cover $300 weekly unemployment bonus for Michiganders during pandemicThe race to develop a vaccine for COVID-19 is now powered by the joint pledge by manufacturers. A USA Today poll found two-thirds of participants said they wont get a coronavirus vaccine as soon as it comes out. Pfizer officials have said theres a chance that phase three data for their vaccine candidate might be available by the end of October, but thats a big leap. Most experts are looking toward the end of 2020, and keep in mind, once a vaccine is available, the actual distribution is still a complicated process.
Johnson & Johnson to stop selling talc-based Johnson's Baby Powder in U.S., Canada
FILE PHOTO: Bottles of Johnson's baby powder are displayed in a store in New York City, U.S., January 22, 2019. REUTERS/Brendan McDermid/File Photo(Reuters) - Johnson and Johnson on Tuesday said it would stop selling its talc-based Johnsons Baby Powder in the United States and Canada as part of a broad reassesment of its consumer product portfolio prompted by the COVID-19 pandemic. J&J faces lawsuits from consumers claiming its talc products, including Johnsons Baby Powder, caused their cancer, but J&J said it remains confident in the products safety. (This story has been refiled to fix story number)
feeds.reuters.comJohnson & Johnson confirms no asbestos in Johnson's Baby Powder
A container of Johnson's baby powder made by Johnson and Johnson sits on a table on October 18, 2019 in San Anselmo, California. Johnson & Johnson said on Tuesday that more tests showed that Johnson's Baby Powder was free of asbestos after U.S. Food and Drug Administration investigations had found trace amounts of the material. The voluntary recall was limited to one lot of Johnson's Baby Powder produced and shipped in the United States in 2018, the company said at the time. That move marked the first time the company recalled its baby powder for possible asbestos contamination, and the first time U.S. regulators have announced a finding of asbestos in the product. J&J faces more than 15,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer.
cnbc.comOklahoma judge miscalculated judgment in opioid case
OKLAHOMA CITY, Okla. - The Oklahoma judge who recently ordered pharmaceutical giant Johnson & Johnson to pay $572 million for its role in the state's opioid crisis says he made a mathematical error when calculating the judgment. As part of the landmark verdict in August, Judge Thad Balkman set aside $107,683,000 to help combat neonatal abstinence syndrome, or NAS. On Tuesday, Balkman agreed with Johnson and Johnson regarding the error. The judge still needs to decide if the court will continue to monitor the opioid crisis for the next 20 years and potentially award more money to the state. Johnson & Johnson has already indicated they will appeal any decision.